| RE50319 | Compounds and methods for treating cancer | Nov 10, 22 | Mar 04, 25 | Dana-Farber Cancer Institute, Inc. |
| RE50320 | APOE mimetic peptides and higher potency to clear plasma cholesterol | May 19, 22 | Mar 04, 25 | The UAB Research Foundation; Anji Pharmaceuticals Inc.; |
| RE50313 | Musculoskeletal stem cell and medium for inducing differentiation of musculoskeletal stem cell | Mar 02, 22 | Feb 25, 25 | CELLATOZ THERAPEUTICS, INC. |
| RE50288 | Factor IX polypeptide mutant, its uses and a method for its production | Jan 12, 23 | Feb 04, 25 | Uniqure Biopharma B.V. |
| RE50230 | Method of treatment of hypoxia inducible factor (HIF)-related conditions | May 25, 22 | Dec 10, 24 | GRIFOLS WORLDWIDE OPERATIONS LIMITED |
| RE50189 | Long term treatment of HIV-infection with TMC278 | Sep 13, 21 | Oct 29, 24 | Janssen Sciences Ireland Unlimited Company |
| RE50083 | URAT1 inhibitor and use thereof | Mar 29, 22 | Aug 20, 24 | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. |
| RE50060 | Topical administration method | Aug 31, 22 | Jul 30, 24 | Novaliq GmbH |
| RE49948 | Aryl ethers and uses thereof | Feb 03, 22 | Apr 30, 24 | Peloton Therapeutics, Inc. |
| RE49918 | Cytotoxic benzodiazepine derivatives | May 10, 21 | Apr 16, 24 | Immunogen Inc. |
| RE49834 | Jak1 selective inhibitors and uses thereof | Nov 15, 21 | Feb 13, 24 | Hangzhou Highlightll Pharmaceutical Co., Ltd. |
| RE49698 | Substituted dihydroquinazolines | Jul 21, 20 | Oct 17, 23 | AIC246 AG & Co. KG |
| RE49579 | Non-peptidic GAPDH aggregation inhibitor | Nov 24, 20 | Jul 18, 23 | University Public Corporation Osaka |
| RE49129 | Method of treatment of hypoxia inducible factor (HIF)-related conditions | Jun 27, 19 | Jul 12, 22 | GRIFOLS WORLDWIDE OPERATIONS LIMITED |
| RE48635 | ERK inhibitors | May 22, 19 | Jul 13, 21 | Eli Lilly and Company |
| RE48557 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | Aug 27, 19 | May 18, 21 | The Regents of the University of Colorado a Body Corporate |
| RE48239 | Heteroaryl pyridone and aza-pyridone compounds | Oct 30, 18 | Oct 06, 20 | Genetech, Inc. |
| RE48183 | Pharmaceutical formulations comprising a pyridylaminoacetic acid compound | Aug 28, 18 | Sep 01, 20 | Santen Pharmaceutical Co. Ltd. |
| RE47528 | Protease for wound conditioning and skin care | Jan 25, 18 | Jul 23, 19 | B.R.A.I.N. Biotechnology Research and Information Network AG |
| RE47451 | Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases | Oct 13, 17 | Jun 25, 19 | Hanmi Pharm. Co. Ltd. |